Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Lauper

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
RMD Open|March 28, 2025
Trends and influences in women authorship in randomised controlled trials in rheumatology: a comprehensive analysis of all published RCTs from 2009 to 2023Kim Lauper, Diana Buitrago-Garcia, Delphine S Courvoisier, et al.
Revue Medicale Suisse|October 25, 2023
[Management of gout in the inpatient setting]Nils Bürgisser, Clément P Buclin, Kim Lauper, et al.
Revue Medicale Suisse|January 20, 2022
[Rheumatology: 2021 update]Axel Finckh, Stéphane Genevay, Michele Iudici, et al.
RMD Open|October 6, 2023
Longitudinal associations between body mass index and changes in disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximabTheresa Burkard, Enriqueta Vallejo-Yagüe, Kim Lauper, et al.
Annals of the Rheumatic Diseases|November 12, 2020
Publishing in 2@84Marco Lanzillotta, Chiara Crotti, Vital Manuel Da Silva Domingues, et al.
Arthritis Care & Research|January 7, 2022
Extent of and Reasons for Discontinuation and Nonpublication of Interventional Trials on Connective Tissue Diseases: An Observational StudyAlejandro Brigante, Barbara Russo, Denis Mongin, et al.
Revue Medicale Suisse|January 17, 2024
[Rheumatology: what's new in 2023]Kim Lauper, Axel Finckh, Stéphane Genevay, et al.
RMD Open|January 10, 2025
Large language models for accurate disease detection in electronic health records: the examples of crystal arthropathiesNils Bürgisser, Etienne Chalot, Samia Mehouachi, et al.
Rheumatology (Oxford, England)|September 27, 2023
Evaluation of serious infections, including Mycobacterium tuberculosis, during treatment with biologic disease-modifying anti-rheumatic drugs: does line of therapy matter?Kim Lauper, Lianne Kearsley-Fleet, James B Galloway, et al.
Nature Reviews. Rheumatology|September 6, 2022
Global epidemiology of rheumatoid arthritisAxel Finckh, Benoît Gilbert, Bridget Hodkinson, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
RMD Open|March 28, 2025
Trends and influences in women authorship in randomised controlled trials in rheumatology: a comprehensive analysis of all published RCTs from 2009 to 2023Kim Lauper, Diana Buitrago-Garcia, Delphine S Courvoisier, et al.
Revue Medicale Suisse|October 25, 2023
[Management of gout in the inpatient setting]Nils Bürgisser, Clément P Buclin, Kim Lauper, et al.
Revue Medicale Suisse|January 20, 2022
[Rheumatology: 2021 update]Axel Finckh, Stéphane Genevay, Michele Iudici, et al.
RMD Open|October 6, 2023
Longitudinal associations between body mass index and changes in disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximabTheresa Burkard, Enriqueta Vallejo-Yagüe, Kim Lauper, et al.
Annals of the Rheumatic Diseases|November 12, 2020
Publishing in 2@84Marco Lanzillotta, Chiara Crotti, Vital Manuel Da Silva Domingues, et al.
Arthritis Care & Research|January 7, 2022
Extent of and Reasons for Discontinuation and Nonpublication of Interventional Trials on Connective Tissue Diseases: An Observational StudyAlejandro Brigante, Barbara Russo, Denis Mongin, et al.
Revue Medicale Suisse|January 17, 2024
[Rheumatology: what's new in 2023]Kim Lauper, Axel Finckh, Stéphane Genevay, et al.
RMD Open|January 10, 2025
Large language models for accurate disease detection in electronic health records: the examples of crystal arthropathiesNils Bürgisser, Etienne Chalot, Samia Mehouachi, et al.
Rheumatology (Oxford, England)|September 27, 2023
Evaluation of serious infections, including Mycobacterium tuberculosis, during treatment with biologic disease-modifying anti-rheumatic drugs: does line of therapy matter?Kim Lauper, Lianne Kearsley-Fleet, James B Galloway, et al.
Nature Reviews. Rheumatology|September 6, 2022
Global epidemiology of rheumatoid arthritisAxel Finckh, Benoît Gilbert, Bridget Hodkinson, et al.
Pageof 7